Zu den Inhalten springen

Tumorzentrum Freiburg - CCCF

DKTK

School of Oncology (SoO)
Training in Translational Oncology for Physicians and Scientists

Physicians and scientists traditionally follow two separate qualification paths, but in translational research they work side by side. The German Cancer Consortium, DKTK has created the first opportunity in Germany for people of both disciplines to specialize in translational oncology. The School of Oncology gives scientists and physicians at the start of their careers the opportunity to familiarize themselves with the requirements of clinical trials, approval processes and the concept of networked, multicenter, interdisciplinary research.

Goals

  • Exchange of medical and clinician scientists.
  • Establishment of structured training in translational cancer research.
  • Establishment of an interactive nationwide network in DKTK.
  • Support of your scientific career development.

Target Audience

Clinician Scientists and Medical Scientists (up to 6 years after obtaining an academic degree).

If you are interested to join DKTK SoO Freiburg, please contact Dr. Anna Dost a.dost@dkfz-heidelberg.de.

Enrollment in the SoO program is ongoing possible!

 

Fellowship Period

A SoO fellowship lasts for a maximum of 3 years, independent from the achievement/conclusion of a DKTK SoO certificate. Extension of time is possible in case of maternity leave or temporary stay abroad.

Find more information on School of Oncology here.  

DKTK SoO Freiburg Members:
DKTK SoO Freiburg Alumni:

August 2021:

Another publication from Dr. Eileen Haring! An original paper Therapeutic targeting of endoplasmic reticulum stress in acute graft-versus-host disease, published in Haematologica

June 2021:

Our new member Dr. Eileen Haring has published her review article in Frontiers in Immunology: Interfering With Inflammation: Heterogeneous Effects of Interferons in Graft- Versus-Host Disease of the Gastrointestinal Tract and Inflammatory Bowel Disease. Congratulations, Eileen!

January 2021:

Dr. Ann-Christin Eder has a succesful start into the new year! She has published four articles, and two of them as a senior author! Very impressive!

1.     Eder AC, Omrane MA, Stadlbauer S, Roscher M, Khoder WY, Gratzke C, Kopka K, Eder M, Meyer PT, Jilg CA, Ruf J: The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging. EJNMMI. (2021).

2.     Dotter H, Boll M, Eder M, Eder AC: Library and Post-Translational Modifications of Peptide-Based Display Systems. Biotechnology Advances (2021).

3.     Matthias J, Engelhardt J, Schäfer M, Bauder-Wüst U, Meyer PT, Haberkorn U, Eder M, Kopka K, Hell SW, Eder AC: Cytoplasmic localization of prostate-specific membrane antigen inhibitors may confer advantages for targeted cancer therapies. Cancer Research. (2021).

4.    Eder AC, Schäfer M, Schmidt J, Bauder-Wüst U, Roscher M, Leotta K, Haberkorn U, Kopka K, Eder M: Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules. JNM. (2021)

December 2020:

Dr. Petya Apostolova has become a DKTK PI after getting DKTK funding for her project "Genomic and transcriptomic analysis of leukemia cells and T cells during anti-PD-1 immunotherapy in the NIFAR (IIT) trial".

October 2020:

Dr. Ann-Christin Eder shared her expertise in Salivary Gland Uptake in 177Lu-PSMA Therapy - Current Status and Novel Approaches as an invited speaker at the EANM 2020 Congress of the European Association of Nuclear Medicine at the Symposium Lutetium Therapy.

August - October 2020:

three months - three new high ranked publications in Dr. Petya Apostolova's publication list:

August: Metabolic conditioning of CD8 + effector T cells for adoptive cell therapy - Nat Metab

September: Glucagon-like peptide 2 for intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans - Blood

October: Metabolic reprogramming of donor T cells enhance graft-versus-leukemia effects in mice and humans - Sci Transl Med

July 2020:

Dr. Petya Apostolova published an article "Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect" in Haematologica as a senior author!

We are pleased to welcome two new fellows to the School of Oncology Freiburg: Dr. Carla Schmidt and Dr. Avantika Ghosh - postdoctoral researchers at the Division of Cancer Research, Department of Thoracic Surgery.

June2020:

Dr. Tamara Werner takes part in the BioBusiness Summer School (June 22-26, 2020). Originally, the summer school was planned to take place in Amsterdam. Because of the current situation, it will be held online with a follow-up retreat next year!

Dr. Petya Apostolova has presented her work "Efficacy and safety of nivolumab in patients with AML relapse after allogeneic transplantation" at the YoungEHA meeting (European Hematology Association).

April 2020:

Dr. Tamara Werner and Dr. Linda Gräßel will represent DKTK Freiburg at European workshop “Young Scientists Meet Patients: Increasing Impact of Cancer Research".

We wish you a productive and interesting time and we are looking forward to hearing your impressions about the workshop!

March 2020:

Our fellow Christoph Müller has published an article “Dynamic 2D and 3D mapping of hyperpolarized pyruvate to lactate conversion in vivo with efficient multi‐echo balanced steady‐state free precession at 3 T

Congratulations, Christoph! We wish you many new ideas and further achievements!

January 2020:

Dr. Petya Apostolova has added an article “Extracorporeal Photopheresis for Colitis Induced by Checkpoint-Inhibitor Therapy” to her impressive publication list. Congratulations!

Prof. Dr. Dr. Melanie Börries
Director of the Institute of Medical Bioinformatics and
Systems Medicine at the Medical Center – University of Freiburg
Breisacherstr. 153
79110 Freiburg
+49 (0) 761 270-84671
m.boerries@dkfz-heidelberg.de

Dr. Anna Dost
Scientific coordinator DKTK Freiburg
Deutsches Krebsforschungszentrum (DKFZ)
Im Neuheimer Feld 280
69120 Heidelberg
+49 (0)761 270 77121
a.dost@dkfz-heidelberg.de

-- Logo: © dkfz.de

 

School of Oncology DKTK

SoO DKTK Homepage